InsidersTradesSigma
Browse the complete record of transactions filed by Bellon Steven F., Directeur Scientifique. Officer active across 1 companies, notably Foghorn Therapeutics Inc.. Aggregated, 1 reports have been logged. The latest transaction was disclosed on 25 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Bellon Steven F. is the Chief Scientific Officer at Foghorn Therapeutics Inc. He is responsible for leading research and development of new products. His role is essential in ensuring that Foghorn remains at the forefront of scientific innovation. His expertise in research and development contributes to the company's mission.